SNW1 Antikörper
Kurzübersicht für SNW1 Antikörper (ABIN7257970)
Target
Alle SNW1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Polyclonal Antibody
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein of human SNW1 (NP_036377.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500-1:2000 IHC 1:50-1:100 IF 1:50-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- SNW1 (SNW Domain Containing 1 (SNW1))
-
Andere Bezeichnung
- SNW1
-
Hintergrund
- This gene, a member of the SNW gene family, encodes a coactivator that enhances transcription from some Pol II promoters. This coactivator can bind to the ligand-binding domain of the vitamin D receptor and to retinoid receptors to enhance vitamin D-, retinoic acid-, estrogen-, and glucocorticoid-mediated gene expression. It can also function as a splicing factor by interacting with poly(A)-binding protein 2 to directly control the expression of muscle-specific genes at the transcriptional level. Finally, the protein may be involved in oncogenesis since it interacts with a region of SKI oncoproteins that is required for transforming activity. Alternative splicing results in multiple transcript variants.
-
Molekulargewicht
-
Observed_MW: 70 kDa/75 kDa
Calculated_MW: 61 kDa
-
Gen-ID
- 22938
-
UniProt
- Q13573
-
Pathways
- Retinoic Acid Receptor Signaling Pathway
Target
-